CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Stock Overview
Canada - TSX-V:CYTO - CA2328211081 - Common Stock
CYTO.CA Key Statistics, Chart & Performance
The current stock price of CYTO.CA is 0.27 CAD. In the past month the price increased by 3.85%. In the past year, price decreased by -3.57%.
About CYTO.CA
Company Profile
Cytophage Technologies Ltd. is a pioneering biotechnology company, which engages in bacteriophage research, product development, and commercialization. The company is headquartered in Oak Bluff, Manitoba. The company went IPO on 2022-02-01. The Company’s business activity is to develop bacteriophages that will reduce and ultimately replace the use of antibiotics for illness prevention and treatment. Bacteriophages are viruses that only infect and kill bacteria. These natural killers of bacteria can overcome cellular or organism-level defenses. The firm is using de-risked and patented technology to advance products that harness the power of bacteriophages to combat bacterial infections affecting human health, animal health, and food security. Its products include FarmPhage, AviPhage, PhageFend, and BoviPhage. FarmPhage is a water-soluble phage solution for livestock. AviPhage is a poultry health product offered by the Company.
Company Info
CYTOPHAGE TECHNOLOGIES LTD
200A-400 Fort Whyte Way
Oak Bluff MANITOBA CA
Employees: 0
Phone: 14162144810
CYTOPHAGE TECHNOLOGIES LTD / CYTO.CA FAQ
What is the stock price of CYTOPHAGE TECHNOLOGIES LTD today?
The current stock price of CYTO.CA is 0.27 CAD. The price increased by 8% in the last trading session.
What is the ticker symbol for CYTOPHAGE TECHNOLOGIES LTD stock?
The exchange symbol of CYTOPHAGE TECHNOLOGIES LTD is CYTO and it is listed on the TSX Venture Exchange exchange.
On which exchange is CYTO.CA stock listed?
CYTO.CA stock is listed on the TSX Venture Exchange exchange.
What is CYTOPHAGE TECHNOLOGIES LTD worth?
CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) has a market capitalization of 16.66M CAD. This makes CYTO.CA a Nano Cap stock.
How many employees does CYTOPHAGE TECHNOLOGIES LTD have?
CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) currently has 0 employees.
What are the support and resistance levels for CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) stock?
CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) has a support level at 0.24 and a resistance level at 0.3. Check the full technical report for a detailed analysis of CYTO.CA support and resistance levels.
Should I buy CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CYTO.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CYTO.CA, evaluating the profitability, health, valuation and growth aspects
- CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Sales and EPS estimates to see what analysts future expectations are.
- CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Stock Chart to make your own analysis
- CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) Latest news and press-releases to stay up to date.
Does CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) stock pay dividends?
CYTO.CA does not pay a dividend.
What is the Price/Earnings (PE) ratio of CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA)?
CYTOPHAGE TECHNOLOGIES LTD (CYTO.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.09).
CYTO.CA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CYTO.CA. When comparing the yearly performance of all stocks, CYTO.CA turns out to be only a medium performer in the overall market: it outperformed 64.86% of all stocks.
CYTO.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CYTO.CA. Both the profitability and financial health of CYTO.CA have multiple concerns.
CYTO.CA Financial Highlights
Over the last trailing twelve months CYTO.CA reported a non-GAAP Earnings per Share(EPS) of -0.09. The EPS increased by 72.89% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -125.33% | ||
| ROE | -267.58% | ||
| Debt/Equity | 0.71 |